The Kidney Transplant Biobank’s mission is to facilitate cutting edge translational research in kidney transplantation. One of the main roles is to house a comprehensive biorepository and provide infrastructure for translational research including biomarker discovery, novel treatment target discovery, outcomes research, molecular genomics and multiomics. The Biobank links clinical data from more than 3000 patients with diseases affecting the kidney transplant with a variety of biospecimens (serum, urine, tissue, plasma, WBC pellet, DNA, RNA and biopsy tissue). We encourage collaboration with any investigator interested in using our resources, specimens or data. We implement the latest technologies in genomics, patient and specimen-based research and work with investigators at the frontiers of kidney transplant research. The Biobank continues to build resources for NIH funded consortia and clinical trials. It also offers a powerful approach to investigating kidney transplant diseases through its comprehensive collection of biological samples linked to complete prospectively collected clinical outcomes data. These data are stored securely in deidentified electronic databases. Our vision is to maintain and grow a state-of-the-art kidney transplant biobank with linked clinical outcomes data for every patient (with consent) managed at the Washington University/Barnes Jewish Hospital kidney transplant program. We see this type of resource as invaluable for the for advancement of our understanding of kidney transplant diseases such as rejection and welcome collaboration with other investigators.
Director: Andrew Malone MD